Concepts (217)
Concepts are derived automatically from a person's publications.
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
- Abatacept
- Adalimumab
- Administration, Oral
- Adolescent
- Adult
- Age Factors
- Age of Onset
- Aged
- Aged, 80 and over
- Algorithms
- Anaphylaxis
- Animals
- Ankylosis
- Antibodies, Antineutrophil Cytoplasmic
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Antigens, CD20
- Anti-Inflammatory Agents
- Antineoplastic Agents, Immunological
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- Antirheumatic Agents
- Area Under Curve
- Arthritis, Gouty
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Autoantibodies
- Autoimmune Diseases
- Autonomic Nervous System Diseases
- Axillary Artery
- Azetidines
- B7-H1 Antigen
- Back Pain
- Betacoronavirus
- Biological Factors
- Biological Products
- Biological Therapy
- Biomarkers
- Biosimilar Pharmaceuticals
- Blood Sedimentation
- Carotid Artery, Common
- Carotid Intima-Media Thickness
- Case-Control Studies
- Cell Count
- Cell Differentiation
- Certolizumab Pegol
- Chromatin Immunoprecipitation
- Clinical Decision-Making
- Clinical Laboratory Techniques
- Clinical Trials, Phase III as Topic
- Cold Temperature
- Communication
- Comorbidity
- Congresses as Topic
- Contrast Media
- Coronavirus Infections
- C-Reactive Protein
- Cross-Sectional Studies
- Cyclophosphamide
- Cytokines
- Dermatomyositis
- Diagnosis, Differential
- Diagnostic Imaging
- Disability Evaluation
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Drug Approval
- Drug Resistance
- Drug Substitution
- Drug Therapy, Combination
- Early Diagnosis
- Edema
- Epigenesis, Genetic
- Etanercept
- Europe
- Evidence-Based Medicine
- Fasciitis
- Fatigue
- Female
- Follow-Up Studies
- Frontal Sinus
- Genetic Markers
- Genotype
- Germany
- Giant Cell Arteritis
- Glucocorticoids
- Gout Suppressants
- Granulomatosis with Polyangiitis
- Group Processes
- Guidelines as Topic
- Hand
- Headache
- Health Transition
- Hemoglobins
- Hospitalization
- Humans
- Hyperuricemia
- Immunogenetic Phenomena
- Immunosorbent Techniques
- Immunosuppressive Agents
- Inflammation
- Infliximab
- Infusions, Intravenous
- Injections, Subcutaneous
- Intercellular Adhesion Molecule-1
- Intercellular Signaling Peptides and Proteins
- Interdisciplinary Communication
- Interferon-gamma
- Interleukin-18
| - Interleukin-2
- Interleukin-4
- Interleukin-9
- Internationality
- Intersectoral Collaboration
- Janus Kinase 1
- Janus Kinase 2
- Janus Kinases
- Longitudinal Studies
- Lupus Erythematosus, Systemic
- Lymphocyte Count
- Magnetic Resonance Imaging
- Maintenance Chemotherapy
- Male
- Methotrexate
- Mice
- Middle Aged
- Mixed Connective Tissue Disease
- Musculoskeletal Diseases
- Myositis
- Nausea
- Neoplasms
- Neutrophils
- Observer Variation
- Odds Ratio
- Off-Label Use
- Optic Neuropathy, Ischemic
- Orbit
- Orbital Pseudotumor
- Osteoarthropathy, Secondary Hypertrophic
- Pandemics
- Paranasal Sinus Diseases
- Paraneoplastic Syndromes
- Patient Safety
- Phospholipids
- Physicians
- Piperidines
- Pneumonia, Viral
- Polymyalgia Rheumatica
- Postoperative Complications
- Practice Guidelines as Topic
- Predictive Value of Tests
- Prednisone
- Prognosis
- Programmed Cell Death 1 Receptor
- Protein Kinase Inhibitors
- Pupil
- Pupil Disorders
- Purines
- Pyrazoles
- Pyrimidines
- Pyrroles
- Qualitative Research
- Quality of Life
- Randomized Controlled Trials as Topic
- Receptors, Interleukin-2
- Receptors, Interleukin-6
- Recovery of Function
- Recurrence
- Reflex, Pupillary
- Registries
- Remission Induction
- Reproducibility of Results
- Respiration, Artificial
- Retrospective Studies
- Rheumatic Diseases
- Rheumatology
- Risk Assessment
- Risk Factors
- Rituximab
- RNA, Messenger
- ROC Curve
- Salivary Glands, Minor
- Scleroderma, Systemic
- Sensitivity and Specificity
- Severity of Illness Index
- Sjogren's Syndrome
- Societies, Medical
- Spondylarthritis
- Spondylarthropathies
- Spondylitis
- Spondylitis, Ankylosing
- Standard of Care
- Still's Disease, Adult-Onset
- Sulfonamides
- Sulfur Hexafluoride
- Synovitis
- Takayasu Arteritis
- Telemedicine
- Temporal Arteries
- Therapeutic Equivalency
- Thorium
- Time Factors
- T-Lymphocytes
- Tomography, X-Ray Computed
- Treatment Failure
- Treatment Outcome
- Tumor Necrosis Factor-alpha
- Ultrasonography
- Ultrasonography, Doppler, Color
- United States
- Uricosuric Agents
- Urticaria
- User-Computer Interface
- Vaccination
- Vision Disorders
- von Willebrand Factor
- Young Adult
|
Schulze-Koops's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(217)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(158)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_